Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy?
Publication
, Journal Article
Kim, HK; Tantry, US; Gurbel, PA; Jeong, YH
Published in: Korean Circulation Journal
July 1, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Korean Circulation Journal
DOI
EISSN
1738-5555
ISSN
1738-5520
Publication Date
July 1, 2020
Volume
50
Citation
APA
Chicago
ICMJE
MLA
NLM
Kim, H. K., Tantry, U. S., Gurbel, P. A., & Jeong, Y. H. (2020). Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy? Korean Circulation Journal, 50. https://doi.org/10.4070/KCJ.2020.0287
Kim, H. K., U. S. Tantry, P. A. Gurbel, and Y. H. Jeong. “Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy?” Korean Circulation Journal 50 (July 1, 2020). https://doi.org/10.4070/KCJ.2020.0287.
Kim HK, Tantry US, Gurbel PA, Jeong YH. Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy? Korean Circulation Journal. 2020 Jul 1;50.
Kim, H. K., et al. “Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy?” Korean Circulation Journal, vol. 50, July 2020. Scopus, doi:10.4070/KCJ.2020.0287.
Kim HK, Tantry US, Gurbel PA, Jeong YH. Another unmet need against residual risk of atherosclerotic cardiovascular disease: Can "thrombin pathway" be a new target for therapy? Korean Circulation Journal. 2020 Jul 1;50.
Published In
Korean Circulation Journal
DOI
EISSN
1738-5555
ISSN
1738-5520
Publication Date
July 1, 2020
Volume
50